Regulatory News
Wednesday, December 28, 2016
BRIEF-Galena Biopharma confirms regulatory pathway for GALE-401
* Galena Biopharma confirms regulatory pathway for GALE-401
(anagrelide controlled release)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment